10.1016/j.jad.2017.04.042 J
1 Introduction Non-alcoholic fatty liver disease (NAFLD) has evolved into a global epidemic, currently affecting approximately 30% of the adult population worldwideequating to over two billion individualsand its prevalence continues to rise in parallel with the global surge in obesity and type 2 diabetes (T2DM) (Powell et al., 2021)
Additional reference Ho MJ, Li EC, Wright JM
Amount in the Published Research Literature The following administration ranges describe the protocols used in the peer-reviewed rodent literature on Dihexa
During these check-ins, the provider will evaluate your progress in weight loss, monitor your medication tolerance, arrange follow-up lab tests or prescription refills, and adjust your care plan as necessary
Storage Guidelines Store in a cool, dry place away from light and moisture